Anzeige
Mehr »
Freitag, 29.08.2025 - Börsentäglich über 12.000 News
Megatrend Uran: Die Nachfrage nach Uran explodiert - greift jetzt Buffetts Erfolgsrezept?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2PBYQ | ISIN: US29350E1047 | Ticker-Symbol: 2Q5
Tradegate
27.08.25 | 20:33
0,210 Euro
-3,67 % -0,008
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
RENOVARO INC Chart 1 Jahr
5-Tage-Chart
RENOVARO INC 5-Tage-Chart
RealtimeGeldBriefZeit
0,2060,21818:11
0,2060,21817:55

Aktuelle News zur RENOVARO Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MiRenovaro Biosciences: Renovaro Inc. Announces Corporate Name Change to Lunai Bioworks, Inc., Reflecting Strategic Focus on AI-Driven Biodefense, Drug Discovery and Advanced Diagnostics243LOS ANGELES, CALIFORNIA / ACCESS Newswire / August 27, 2025 / Renovaro Inc. (NASDAQ:RENB) today announced that it will change its corporate name to Lunai Bioworks, Inc. to better reflect its strategic...
► Artikel lesen
DiRenovaro Inc. firmiert in Lunai Bioworks Inc. um, Tickersymbol an der NASDAQ bleibt bestehen4
DiRENOVARO INC. - 8-K, Current Report1
08.08.Renovaro Biosciences: Renovaro Inc. Mentioned in RealClearDefense Article on AI and Biodefense Risks304LOS ANGELES, CALIFORNIA / ACCESS Newswire / August 8, 2025 / Renovaro Inc. (NASDAQ:RENB) was referenced in a recent RealClearDefense article titled "AI Can Be Used to Develop Biological and Chemical...
► Artikel lesen
RENOVARO Aktie jetzt für 0€ handeln
06.08.RENOVARO INC. - 8-K, Current Report3
28.07.Renovaro Biosciences: Renovaro Secures Key AI Patents, Strengthening Market Position in $20B Biomedical AI Sector289Strategic IP expansion protects federated learning technology driving pharma partnerships, biosecurity initiatives, and precision medicine growth LOS ANGELES, CALIFORNIA / ACCESS Newswire / July 28...
► Artikel lesen
27.07.Renovaro: Aufsichtsratsvorsitzender Maurice van Tilburg tritt im August 2025 zurück5
25.07.RENOVARO INC. - 8-K, Current Report1
17.07.Renovaro Biosciences: Peer-Reviewed Study Validates Renovaro's Genetically Engineered Dendritic Cell Therapy with Potent Anti-Tumor Efficacy270Landmark preclinical data validate Renovaro's platform representing a step forward in the fight against pancreatic and solid tumors LOS ANGELES, CALIFORNIA / ACCESS Newswire / July 17, 2025 / Renovaro...
► Artikel lesen
14.07.RENOVARO INC. - 8-K, Current Report3
09.07.Renovaro Biosciences: Renovaro Strengthens Balance Sheet Through Debt Conversion and Advances AI-Driven Initiatives289LOS ANGELES, CA / ACCESS Newswire / July 9, 2025 / Renovaro Inc. (NASDAQ:RENB), an AI-driven precision medicine company, today announced that senior debt holders have agreed to convert an aggregate...
► Artikel lesen
30.06.Renovaro Biosciences: Renovaro Launches AI-Based Neurotoxin Countermeasure Initiative Addressing Emerging National Security Needs297LOS ANGELES, CALIFORNIA / ACCESS Newswire / June 30, 2025 / Renovaro Inc.'s (NASDAQ:RENB) wholly owned subsidiary BioSymetrics has unveiled a proprietary AI-based zebrafish screening platform designed...
► Artikel lesen
05.06.RENOVARO INC. - 8-K, Current Report5
03.06.Renovaro subsidiary secures patent for drug discovery AI9
03.06.Renovaro Inc: Renovaro Secures Key U.S. Patent to Strengthen AI-Driven Drug Discovery and Diagnostics Platform3
27.05.Predictive Oncology to defend against Renovaro's claims in court9
27.05.Predictive Oncology Inc.: Court Denies Renovaro Motion for an Expedited Trial in July248PITTSBURGH, May 27, 2025 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a leader in AI-driven drug discovery, today issued the following statement regarding its dispute with Renovaro...
► Artikel lesen
22.05.Renovaro Inc. Announces Expedited Trail for 2025 Lawsuit to Enforce Binding Merger Agreement with Predictive Oncology132LOS ANGELES, May 22, 2025 (GLOBE NEWSWIRE) -- Renovaro Inc. (NASDAQ: RENB), a TechBio leader focused on next-generation diagnostics, drug discovery, and genetically enhanced cancer therapies, today...
► Artikel lesen
15.05.RENOVARO INC. - 10-Q, Quarterly Report4
14.05.Renovaro launches AI platform to advance neurology drug discovery1
Weiter >>
53 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,10